                         SEQUENCE LISTING

<110>  THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
 
<120>  NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER 
       IMMUNOTHERAPY

<130>  91482.242PCT

<150>  US 63/018,059
<151>  2020-04-30

<160>  54    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  1

Asn Asn Pro Pro Gly Ala Tyr Ile Phe Thr Val Ser Ala Met Asp 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  2

Leu Tyr Leu Ala Phe Pro Val Ala Phe Cys Ile Phe Met Val Arg 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  3

Pro Ile Pro Gln Glu Tyr Val Leu Phe Leu Cys Pro Thr Gly Pro 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  4

Ser His His His Thr Met Met Val Gln Ala Ile Thr Phe Ile Phe 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  5

Gly Ile Val Phe Ser Tyr Ile His Ile Ile Ser Ser Ile Leu Arg 
1               5                   10                  15  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  6

Ser Ser Gln Leu His His Ser Met Tyr Phe Phe Leu Ser His Leu 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  7

Ser Gly Gly Pro Gly Ser Glu Lys Ser Leu Leu Leu Ser Lys Trp 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  8

Val Pro Pro Leu Arg Pro Asn Pro Ala Leu Pro Pro Leu Pro Thr 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  9

Pro Leu Arg Cys Ser Ser Pro Leu Ala Ala Pro Thr Phe Leu Arg 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  10

Lys Ala Ile Ser Asn Pro His Met Tyr Ala Val Asp Met Ser Ser 
1               5                   10                  15  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  11

Glu Asn Ile His Gly Pro Trp Asp Glu Ala Glu Ile Lys Lys Asp 
1               5                   10                  15  


<210>  12
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  12

Phe Ser Pro Thr Arg Asp Val Ile Leu Tyr Tyr Val Asn Leu Lys 
1               5                   10                  15  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  13

Phe Phe Gly Pro Leu Ile Leu Phe Tyr Thr Trp Pro Phe Pro Thr 
1               5                   10                  15  


<210>  14
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  14

Met Gly Pro Pro Gly Gly Phe Gln Glu Phe Asn Phe Ile Val Pro 
1               5                   10                  15  


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  15

Asp Thr Ile Ser Arg Ala Val Phe Pro Leu Ala Phe Leu Ile Phe 
1               5                   10                  15  


<210>  16
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  16

Ser Phe Lys Tyr Tyr Ala His Ala Thr Ser Leu Ala Gly His Leu 
1               5                   10                  15  


<210>  17
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  17

Leu Asn Met Pro Glu Leu Asn Ile Thr Val Tyr Lys Asp Phe Ser 
1               5                   10                  15  


<210>  18
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  18

Gly Ile Arg Lys Ala Lys Lys Arg Asn Tyr Ala Phe Leu Trp Asp 
1               5                   10                  15  


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  19

Pro His Leu Lys Asp Trp Gln Ile Phe His Gln Ala Leu Leu Arg 
1               5                   10                  15  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  20

Gly Leu Gly Lys His Gly Phe Ile Met Glu Met Asn Ala Phe Gly 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  21

Asn His Ala Phe Lys Cys Lys His Cys Gly Lys Pro Phe Gly Thr 
1               5                   10                  15  


<210>  22
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  22

Leu Asp Lys His Trp His Leu Glu Cys Phe Lys Cys Lys Thr Cys 
1               5                   10                  15  


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  23

Pro Cys Val Phe Leu Val Asn Cys Leu Pro Phe Cys Arg Thr His 
1               5                   10                  15  


<210>  24
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  24

Lys Val Asp Ile Met Pro Pro His Val Phe Phe Tyr Val Asp Lys 
1               5                   10                  15  


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  25

Lys Ala Glu Ile Leu Ser Ser Leu Gly Ala Leu Tyr Tyr Asn Thr 
1               5                   10                  15  


<210>  26
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  26

Pro His Gly Tyr Glu Ile Lys Phe Ile Phe Gly Ile Pro Leu Asp 
1               5                   10                  15  


<210>  27
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  27

Ile Arg Glu Asn Phe Leu Phe Leu Asp Val Phe Phe Glu Ala Leu 
1               5                   10                  15  


<210>  28
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  28

Gln His Asp Lys Glu Gln Lys Met Ile Gly Ser Val Ser Gln Ser 
1               5                   10                  15  


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  29

Gln Glu Asn Thr Cys Asn Ile Thr Ile Glu Gly Leu Asp Ala Glu 
1               5                   10                  15  


<210>  30
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  30

Val Glu Asp Pro Val Tyr Gln Val Ile Ser Glu Thr Ser Arg Asp 
1               5                   10                  15  


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  31

Leu Gly Phe Phe Lys Gln Asn Glu His Gln Asn Leu Leu Phe Val 
1               5                   10                  15  


<210>  32
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  32

Thr Lys Phe Ile Leu Val Glu Phe Pro Gly Ser Leu Ser Met Arg 
1               5                   10                  15  


<210>  33
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  33

Ile Leu Leu Glu Asn Thr Asp Leu Ser Ala Leu Trp Tyr Leu Tyr 
1               5                   10                  15  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  34

Ser Glu Lys Leu Ser His Leu Lys Ile Thr Gly Asp Ser Phe Leu 
1               5                   10                  15  


<210>  35
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  35

Lys Gln Glu Phe Val Lys Pro Lys Ile Val Ser Arg Glu Gly Gly 
1               5                   10                  15  


<210>  36
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  36

Asp Cys Phe Ser Thr Asn Lys Leu Leu Thr Tyr Glu Ala Leu Gly 
1               5                   10                  15  


<210>  37
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  37

Lys Ala Ile Glu Lys Glu Met Lys Val Thr Ala Leu Pro Pro Lys 
1               5                   10                  15  


<210>  38
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  38

Asp Lys Glu Phe Val Lys Phe Asn Arg Met His Ala Val Asn Gly 
1               5                   10                  15  


<210>  39
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  39

Ala Arg Ala Leu Ile Leu Leu Pro Thr Arg Glu Leu Ala Leu Gln 
1               5                   10                  15  


<210>  40
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  40

Trp Gln Pro Gln Ser His Ser Arg Gln Gly His Gly Thr Ser Pro 
1               5                   10                  15  


<210>  41
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  41

Ser Ile His Leu Leu Thr Ser Arg Ala Thr Asn Ser Gln Leu Phe 
1               5                   10                  15  


<210>  42
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  42

Gln Val Ile Ala Leu His Cys Ser Gln Ala Gln Ser Ser Val Ser 
1               5                   10                  15  


<210>  43
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  43

Leu Arg Cys Met Gly Asn Asn Gly Ile Cys Arg Ala Ser Cys Lys 
1               5                   10                  15  


<210>  44
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  44

Trp Ile Thr Pro Leu Asp His Leu Val Ala Phe Pro Thr Arg Val 
1               5                   10                  15  


<210>  45
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  45

Ala Ile Lys Thr Leu Lys Ser Gly His Met Asp Arg Gln Arg Arg 
1               5                   10                  15  


<210>  46
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  46

Ala Leu Phe Asp Gly Asp Ser His Leu Ser Thr Glu Asn Pro Ala 
1               5                   10                  15  


<210>  47
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  47

Pro Ser Pro Thr Val Leu Arg Ala His Ala Glu Met Ala Leu Asp 
1               5                   10                  15  


<210>  48
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Neoantigen

<400>  48

Asp Met Leu Ser Gln Thr Asn Cys Phe Val Ser Leu Trp Leu Pro 
1               5                   10                  15  


<210>  49
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  49

Pro Val Ser Lys Met Arg Met Ala Thr Pro Leu Leu Met Gln Ala 
1               5                   10                  15  


<210>  50
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  50

Ala Ala Met Ala Ala Ala Ala Ala Ala Ala Met Ala Ala 
1               5                   10              


<210>  51
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  51

Ala Ala Met Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala 
1               5                   10              


<210>  52
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  52

Ala Ala Phe Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala 
1               5                   10              


<210>  53
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder

<400>  53

Ala Ser Met Ser Ala Ala Ser Ala Ala Ser Met Ala Ala 
1               5                   10              


<210>  54
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Spaceholder


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa can be any naturally occurring amino acid

<400>  54

Ala Ala Xaa Ala Ala Ala Ala Ala Ala Ala Xaa Ala Ala 
1               5                   10              


